Evidence map›Paper›PMID 35098981›Full record

SynthesisThe journal of prevention of Alzheimer's disease2022

Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review.

A R Shaw, J Perales-Puchalt, E Johnson, P Espinoza-Kissell, M Acosta-Rullan, S Frederick, A Lewis, H Chang, J Mahnken, E D Vidoni

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in The journal of prevention of Alzheimer's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 7 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 7 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Evaluating the Use of Anxiety Patient-Reported Outcome Measures (PROMs) in Dementia Clinical Trials: A Systematic Review.Health expectations : an international journal of public participation in health care and health policy · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Pathways to Racial/Ethnic Inequalities in Dementia.Annual review of clinical psychology · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

A R ShawEric Vidoni, 4350 Shawnee Mission Parkway, Fairway, KS, 66205, USA, Email: evidoni@kumc.edu; Phone: 913-588-5312; Fax: 913-945-5035.
J Perales-Puchalt
E Johnson
P Espinoza-Kissell
M Acosta-Rullan
S Frederick
A Lewis
H Chang
J Mahnken
E D Vidoni
Shawnee Mission Medical Center · USUniversity of Kansas Medical Center · US

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JEFFREY Murray BURNS, RUSSELL H. SWERDLOW · 2021 to 2026
$25.3M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VIDONI, ERIC DENNIS · 2011 to 2020
$16.6M
Feasibility of a Novel Systems Approach for Improving Utilization of Alzheimer's Disease Services Among Latinos Attending Primary Care PracticesK01MD014177 · NIMHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PERALES PUCHALT, JAIME · 2020 to 2024
$571k
Brain Healthy Soul Food Diet Intervention Among Older African AmericansK01AG072034 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SHAW, ASHLEY RICHELLE · 2021 to 2024
$507k
NIA NIH HHS K01 AG072034NIA NIH HHS L60 AG069211NIA NIH HHS P30 AG035982NIA NIH HHS P30 AG072973NIMHD NIH HHS K01 MD014177
6 · The paper itself

Abstract

Despite older racial and ethnic minorities (REMs) being more likely to develop dementia they are underrepresented in clinical trials focused on neurological disorders. Inclusion of REMs in dementia prevention studies is vital to reducing the impact of disparities in dementia risk. We conducted a systematic review to characterize the number of REM enrolled in brain health and prevention randomized controlled trials (RCTs). RTCs published from January 1, 2004 to April 21, 2020 were included. Participants were normal cognitive adults aged 45 years and older who participated in a Phase II or Phase III U.S. based preventative trial. Analyses were performed to examine differences in trial characteristics between RCTs that did and those that did not report race/ethnicity and to calculate the pooled proportion of each racial/ethnic group in randomized brain healthy prevention trials. A total of 42 studies consisting of 100,748 participants were included in the final analyses. A total of 26 (62%) reported some racial/ethnic identity data. The pooled proportion of REM participants was 0.256 (95% CI, 0.191, 0.326). There is a lack of racial/ethnic reporting of participants and REMs remain underrepresented in brain health prevention RCTs.

Indexed as

DementiaEthnicityAdultEthnic and Racial MinoritiesHumansMinority GroupsResearch DesignagingAlzheimer’s diseasedementiapreventionunderrepresented minorities

Identifiers

PMID35098981
PMCPMC8804327
OpenAlexW3203130144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.